Drug intelligence / Profile preview

Magnoliae flos extract

Development stage
Unknown
Lead developer
Hankook Shinyak
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Intranasal, Oral, Topical
01

Overview

Magnoliae flos extract is a botanical extract derived from the dried flower buds of *Magnolia denudata*, *Magnolia fargesii*, *Magnolia biondii*, or related *Magnolia* species (family Magnoliaceae). It has a long history of use in traditional Asian medicine for treating allergic rhinitis, sinusitis, nasal congestion, headache, and toothache. The extract exerts its therapeutic effects primarily by inhibiting store-operated calcium entry (SOCE) via the ORAI1 channel, blocking the calcium-activated chloride channel anoctamin-1 (ANO1), and acting as an antagonist of the platelet-activating factor receptor (PTAFR). These actions lead to the inhibition of mast cell degranulation, histamine release, and cytokine secretion from T cells. A specific standardized extract, NDC-052, has been clinically investigated as an oral add-on therapy for mild-to-moderate asthma in patients receiving inhaled corticosteroids. Additionally, the extract has been researched for its neuroprotective, anti-inflammatory, and potential anti-atopic dermatitis properties.

Other names
Biond magnolia flower extractFlos Magnoliae extractMagnolia biondii extractMagnolia denudata extractMagnolia fargesii extractMagnolia flower extractMagnolia liliflora extractShin-Yi extractXinyi extract
02

Targets

ANO1 (Anoctamin-1)ADRB1 (β1)PTAFR (Platelet-activating factor receptor)ORAI1 (Calcium release–activated calcium channel protein 1)

Beyond the preview

Go deeper on Magnoliae flos extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Magnoliae flos extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call